<DOC>
	<DOCNO>NCT03091738</DOCNO>
	<brief_summary>To study effect ramelteon , melatonin receptor agonist , sleep quality , duration cognitive function cirrhotics insomnia . Patients cirrhosis difficulty sleep quality , adversely affect health-related quality life . It assume sleep disturbance relate hepatic encephalopathy ( HE ) patient . However , several recent report indicate perfect concordance cognition relate sleep disturbance . The mechanism change clear , although evidence melatonin-delayed phase patient well difficulty excretion pattern cortisol . Ghrelin orexigenic hormone produce stomach stimulates appetite also profound effect sleep . Our group demonstrate substantial alteration ghrelin secretion cirrhosis correlate poor slow-wave sleep . In healthy individual , ghrelin injection encourage slow-wave sleep sleep deprivation increase ghrelin level . The role ghrelin sleep disturbance cirrhosis determine . Prior study also lack use overnight polysomnography tool rely either actigraphy questionnaire . There need detailed mechanistic therapeutic approach analyze sleep disturbance cirrhosis . Also therapy sleep disturbance cirrhosis largely empirical . Prior study evaluate hydroxyzine run risk precipitate HE . Ramelteon melatonin analog FDA-approved use insomnia potentially useful restore sleep-wake cycle cirrhosis-associated sleep disturbance . The investigator aim study impact FDA-approved ramelteon sleep quality ( use questionnaire sleep diary ) patient cirrhosis .</brief_summary>
	<brief_title>Ramelteon Treatment Insomnia Cirrhosis</brief_title>
	<detailed_description>This study prospective study patient compensate cirrhosis This study divide screen post-ramelteon visit . For study , subject cirrhosis recruit hepatology clinic . Screening : All subject come initial screen visit CRSU point follow procedure perform : 1 . Vitals , include BMI 2 . Neck circumference 3 . Skinfold thickness waist-hip ratio 4 . Beck Depression Inventory ( BDI ) 5 . Sickness impact profile overall HRQOL Questionnaires regard sleep : 1 . Berlin questionnaire 2 . STOP Bang questionnaire 3 . Epworth sleepiness scale ( ESS ) 4 . Pittsburgh sleep quality index ( PQSI ) Cirrhotic patient either criterion ( ) neck circumference &gt; 17 inch men &gt; 16 inch woman ( b ) Positive Berlin questionnaire exclude highly suggestive sleep disturbance OSA . The investigator also exclude patient evidence moderate severe depression Beck Depression Inventory ( score â‰¥20 ) without suicide question . All enrol study participant perform 5 paper-pencil two computerized test intelligence last approximately 35 minute total . RAMELTEON THERAPY : The subject ' study chart , current medication , medical history pregnancy test assessed sleep physician VCU , decide patient would benefit ramelteon . The criterion use insomnia along absence OSA questionnaires . Ramelteon FDA-approved selective melatonin receptor 1 2 analog indicate use insomnia . The dose use 8 mg , low possible dose . If sleep specialist believe particular cirrhotic patient candidate therapy , clinically prescribe ramelteon detailed face face visit explain risk benefit . Ramelteon indicate patient severe hepatic impairment ( define Child Class C ) , therefore , patient include study . If patient agrees take medicine , dispense investigational pharmacy , store study . Patients ask complete medication sleep diary duration drug therapy maximum 15 day . Within 15 day drug initiation , patient ask complete sleep questionnaire cognitive test similar describe visit 1 .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>Child class A cirrhosis proven biopsy , radiology endoscopic evidence varix Able give inform consent Patient unwilling start therapy Allergic reaction ramelteon past Obstructive sleep apnea Periodic limb movement disorder Moderate severe depression Unable give inform consent Night shift worker Intercontinental travel within last 4 week Renal insufficiency dialysis Current alcohol illicit drug use Diabetes Mellitus use insulin therapy Use chronic hypnotic medication per week 56 time per month</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>sleep</keyword>
</DOC>